Patients aged 65 and older receiving thyroid hormone therapy with low thyrotropin levels face an increased risk of dementia and cognitive issues. The study analyzed over 65,000 patients, highlighting the association between thyrotoxicosis and incident cognitive disorders. Women were more prone to low thyrotropin levels and overtreatment. Primary care physicians are advised to be cautious in prescribing thyroid hormone therapy to older patients to avoid overtreatment and potential cognitive disorders. The study emphasizes the importance of considering the risks versus benefits of thyroid hormone therapy in older adults.
To Another Language
from source content
www.medscape.com
Key Insights Distilled From
by Karon Warren at www.medscape.com 11-02-2023
https://www.medscape.com/viewarticle/998036Deeper Inquiries